Barclays’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-95,436
| Closed | -$9.26M | – | 4489 |
|
|
2019
Q3 | $9.26M | Sell |
95,436
-49,975
| -34% | -$4.85M | 0.01% | 805 |
|
|
2019
Q2 | $14.9M | Buy |
145,411
+91,429
| +169% | +$9.36M | 0.01% | 689 |
|
|
2019
Q1 | $6.15M | Buy |
53,982
+40,230
| +293% | +$4.58M | ﹤0.01% | 898 |
|
|
2018
Q4 | $538K | Sell |
13,752
-4,742
| -26% | -$186K | ﹤0.01% | 2214 |
|
|
2018
Q3 | $1.01M | Buy |
18,494
+12,982
| +236% | +$708K | ﹤0.01% | 2253 |
|
|
2018
Q2 | $457K | Sell |
5,512
-10,559
| -66% | -$875K | ﹤0.01% | 2337 |
|
|
2018
Q1 | $1.07M | Buy |
16,071
+11,687
| +267% | +$777K | ﹤0.01% | 1760 |
|
|
2017
Q4 | $225K | Buy |
4,384
+3,763
| +606% | +$193K | ﹤0.01% | 2581 |
|
|
2017
Q3 | $55K | Sell |
621
-1,141
| -65% | -$101K | ﹤0.01% | 2918 |
|
|
2017
Q2 | $105K | Sell |
1,762
-2,548
| -59% | -$152K | ﹤0.01% | 2747 |
|
|
2017
Q1 | $228K | Buy |
4,310
+1,425
| +49% | +$75.4K | ﹤0.01% | 2413 |
|
|
2016
Q4 | $144K | Buy |
2,885
+802
| +39% | +$40K | ﹤0.01% | 2459 |
|
|
2016
Q3 | $124K | Sell |
2,083
-4,372
| -68% | -$260K | ﹤0.01% | 2355 |
|
|
2016
Q2 | $330K | Buy |
6,455
+4,824
| +296% | +$247K | ﹤0.01% | 1938 |
|
|
2016
Q1 | $47K | Buy |
1,631
+1,462
| +865% | +$42.1K | ﹤0.01% | 2557 |
|
|
2015
Q4 | $8K | Buy |
169
+127
| +302% | +$6.01K | ﹤0.01% | 2853 |
|
|
2015
Q3 | $2K | Sell |
42
-3,571
| -99% | -$170K | ﹤0.01% | 3599 |
|
|
2015
Q2 | $217K | Buy |
3,613
+3,507
| +3,308% | +$211K | ﹤0.01% | 2049 |
|
|
2015
Q1 | $8K | Buy |
+106
| New | +$8K | ﹤0.01% | 3500 |
|